WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, November 12, 2008, 28(46):12125-12135; doi:10.1523/JNEUROSCI.3400-08.2008

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Related articles in J. Neurosci.
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Racz, I.
Right arrow Articles by Maldonado, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Racz, I.
Right arrow Articles by Maldonado, R.

 Previous Article  |  Next Article 

Neurobiology of Disease
Crucial Role of CB2 Cannabinoid Receptor in the Regulation of Central Immune Responses during Neuropathic Pain

Ildiko Racz,1 * Xavier Nadal,3 * Judith Alferink,1,2 * Josep E. Baños,3 Jennifer Rehnelt,1 Miquel Martín,3 Belén Pintado,4 Alfonso Gutierrez-Adan,4 Elena Sanguino,5 Jorge Manzanares,5 Andreas Zimmer,1 and Rafael Maldonado3

1Institute of Molecular Psychiatry and 2Department of Psychiatry, University of Bonn, 53105 Bonn, Germany, 3Laboratori de Neurofarmacologia, Facultat de Ciències de la Salut i de la Vida, Universitat Pompeu Fabra, Parc de Recerca Biomèdica de Barcelona, 08003 Barcelona, Spain, 4Departamento de Reproducción Animal y Conservación de Recursos Zoogenéticos, Instituto Nacional de Investigación y Tecnología Agraria, 28040 Madrid, Spain, and 5Instituto de Neurociencias de Alicante, Universidad Miguel Hernández–Consejo Superior de Investigaciones Científicas, 03550 Alicante, Spain

Correspondence should be addressed to either of the following: Andreas Zimmer, Institute of Molecular Psychiatry, University of Bonn, Sigmund-Freud-Strasse 25, 53105 Bonn, Germany, Email: a.zimmer{at}uni-bonn.de; or Rafael Maldonado, Laboratori de Neurofarmacologia, Facultat de Ciéncies de la Salut i de la Vida, Universitat Pompeu Fabra, C/Dr Aiguader 80, 08003 Barcelona, Spain, Email: rafael.maldonado{at}upf.edu

Neuropathic pain is a clinical manifestation of nerve injury difficult to treat even with potent analgesic compounds. Here, we used different lines of genetically modified mice to clarify the role played by CB2 cannabinoid receptors in the regulation of the central immune responses leading to the development of neuropathic pain. CB2 knock-out mice and wild-type littermates were exposed to sciatic nerve injury, and both genotypes developed a similar hyperalgesia and allodynia in the ipsilateral paw. Most strikingly, knock-outs also developed a contralateral mirror image pain, associated with an enhanced microglial and astrocytic expression in the contralateral spinal horn. In agreement, hyperalgesia, allodynia, and microglial and astrocytic activation induced by sciatic nerve injury were attenuated in transgenic mice overexpressing CB2 receptors. These results demonstrate the crucial role of CB2 cannabinoid receptor in modulating glial activation in response to nerve injury. The enhanced manifestations of neuropathic pain were replicated in irradiated wild-type mice reconstituted with bone marrow cells from CB2 knock-outs, thus demonstrating the implication of the CB2 receptor expressed in hematopoietic cells in the development of neuropathic pain at the spinal cord.

Key words: CB2 cannabinoid receptor; microglia; astrocytes; neuropathic pain; bone marrow chimera; neuroinflammation


Received July 18, 2008; revised Sept. 19, 2008; accepted Sept. 26, 2008.

Correspondence should be addressed to either of the following: Andreas Zimmer, Institute of Molecular Psychiatry, University of Bonn, Sigmund-Freud-Strasse 25, 53105 Bonn, Germany, Email: a.zimmer{at}uni-bonn.de; or Rafael Maldonado, Laboratori de Neurofarmacologia, Facultat de Ciéncies de la Salut i de la Vida, Universitat Pompeu Fabra, C/Dr Aiguader 80, 08003 Barcelona, Spain, Email: rafael.maldonado{at}upf.edu


Related articles in J. Neurosci.:

This Week in The Journal

J. Neurosci. 2008 28: i. [Full Text]  



This article has been cited by other articles:


Home page
Mult SclerHome page
M. Melanson, P. Miao, D. Eisenstat, Y. Gong, X. Gu, K. Au, W. Zhu, F. Begum, E. Frost, and M. Namaka
Experimental autoimmune encephalomyelitis-induced upregulation of tumor necrosis factor-alpha in the dorsal root ganglia
Multiple Sclerosis, October 1, 2009; 15(10): 1135 - 1145.
[Abstract] [PDF]


Home page
J. Neurosci.Home page
I. Racz, X. Nadal, J. Alferink, J. E. Banos, J. Rehnelt, M. Martin, B. Pintado, A. Gutierrez-Adan, E. Sanguino, N. Bellora, et al.
Interferon-{gamma} Is a Critical Modulator of CB2 Cannabinoid Receptor Signaling during Neuropathic Pain
J. Neurosci., November 12, 2008; 28(46): 12136 - 12145.
[Abstract] [Full Text] [PDF]



-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-